Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumentin 44 MRE Image Quality in Healthy Volunteers
NCT05781490Phase 2Completed
- Sponsor
- Lumen Bioscience
- Start
- Jan 2023
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Lumentin, sponsored by Lumen Bioscience. Primary endpoints: Visual Evaluation of MRE Images - Motility at Day 1, Visual Evaluation of MRE Images - Artefacts at Day 1 and 2 more. Started Jan 2023; status: completed.
02
Drugs
Lumentin
Beyond the preview
Go deeper on NCT05781490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05781490.